Journal of the Formosan Medical Association
Volume 108, Issue 7 , Pages 554-559, July 2009

Cadmium Concentration and Metallothionein Expression in Prostate Cancer and Benign Prostatic Hyperplasia of Humans

  • Jane-Dar Lee

      Affiliations

    • Division of Urology, Department of Surgery, Taichung Armed Forces General Hospital, Taiwan
    • Central Taiwan University of Science and Technology, Taiwan
    • ,
  • Su-Mei Wu

      Affiliations

    • Department of Aquatic Biosciences, National Chiayi University, Yuanshan Veterans Hospital, Taiwan
    • ,
  • Lieng-Yi Lu

      Affiliations

    • Division of Urology, Department of Surgery, Taichung Armed Forces General Hospital, Taiwan
    • ,
  • Ya-Tang Yang

      Affiliations

    • Department of Pathology, Taichung Armed Forces General Hospital, Taiwan
    • ,
  • Shaw-Yeu Jeng

      Affiliations

    • Department of Surgery, Yuanshan Veterans Hospital, Taiwan
    • Central Taiwan University of Science and Technology, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Shaw-Yeu Jeng, Department of Surgery, Yuanshan Veterans Hospital, 386 Rongguang Road, Yuanshan Township, Yilan 264, Taiwan

Received 27 March 2008; received in revised form 26 May 2008; accepted 19 January 2009.

Article Outline

Background/Purpose

Cadmium (Cd) causes various genitourinary disorders and is a carcinogen for prostate cancer. Metallothionein (MT) is a protein that detoxifies heavy metals. We evaluated changes in Cd concentration and MT expression in human prostate cancer (CaP) and benign prostatic hyperplasia (BPH). Our goal was to clarify the relationship between Cd concentration and MT expression in prostatic diseases.

Methods

The experimental group consisted of 18 patients who underwent radical prostatectomy for CaP. The control group consisted of 35 patients who underwent transurethral resection of the prostate for BPH. Tissue samples were acquired from the gross tumor site and from resected chips. We determined Cd concentration by atomic absorption, MT expression by immunoblotting, and immunohistochemical staining. The significance of between-group differences for these outcomes was analyzed using Student's t tests.

Results

There was no statistically significant difference in Cd concentration between the CaP and BPH groups. Immunoblots from both groups revealed a single band. The relative intensity of the MT band was 0.58 ± 0.09 in the BPH group and 0.17 ± 0.03 in the CaP group. MT expression in patients with BPH was 3.4-fold higher than in those with CaP.

Conclusion

MT may bind heavy metals and protect patients from CaP. Additional studies are needed to reveal the factors that influence the expression of MT in prostate epithelial cells, and to analyze the free and compound forms of Cd at the same time.

Key Words:  benign prostatic hyperplasia , cadmium , metallothionein , prostate cancer

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Benoff S , Jacob A , Hurley IR . Male infertility and environmental exposure to lead and cadmium . Hum Reprod Update . 2000;6:107–121
  2. Achanzar WE , Achanzar KB , Lewis JG , et al.   Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis . Toxicol Appl Pharmacol . 2000;164:291–300
  3. Waalkes MP , Rehm S . Cadmium and prostate cancer . J Toxicol Environ Health . 1994;43:251–269
  4. Goyer RA , Liu J , Waalkes MP . Cadmium and cancer of prostate and testis . Biometals . 2004;17:555–558
  5. Roesijadi G . Metallothioneins in metal regulation and toxicity in aquatic animals . Aquat Toxicol . 1992;22:81–114
  6. Kusakabe T , Nakajima K , Suzuki K , et al.   The changes of heavy metal and metallothionein distribution in testis induced by cadmium exposure . Biometals . 2008;21:71–81
  7. Endo T , Yoshikawa M , Ebara M , et al.   Immunohistochemical metallothionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agents . J Gastroenterol . 2004;39:1196–1201
  8. Jasani B , Schmid KW . Significance of metallothionein overexpression in human tumours . Histopathology . 1997;31:211–214
  9. Garrett SH , Sens MA , Shukla D , et al.   Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines . Prostate . 1999;41:196–202
  10. El Sharkawy SL , Abbas NF , Badawi MA , et al.   Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions . J Clin Pathol . 2006;59:1171–1174
  11. Garrett SH , Sens MA , Shukla D , et al.   Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer . Prostate . 2000;43:125–135
  12. Wu SM , Weng CF , Yu MJ , et al.   Cadmium-inducible metallothionein in tilapia (Oreochromis mossambicus) . Bull Environ Contam Toxicol . 1999;62:758–768
  13. Chang MH , Lin HC , Hwang PP . Effects of cadmium on the kinetics of calcium uptake in developing tilapia larvae, Oreochromis mossambicus . Fish Physiol Biochem . 1997;16:459–470
  14. Wu SM . The effects of ambient cadmium on the accumulation cadmium and metallothionein in tilapia (Oreochromis mossambicus) tissues . Chinese Bioscience . 2001;44:1–9
  15. Wu SM , Weng CF , Hwang JC , et al.   Metallothionein induction in early larval stages of tilapia (Oreochromis mossambicus) . Physiol Biochem Zool . 2000;73:531–537
  16. Suzuki T , Umeyama T , Ohma C , et al.   Immunohistochemical study of metallothionein in normal and benign prostatic hyperplasia of human prostate . Prostate . 1991;19:35–42
  17. Ogunlewe JO , Osegbe DN . Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate . Cancer . 1989;63:1388–1392
  18. Cai L , Deng DX , Jiang J , et al.   Induction of metallothionein synthesis with preservation of testicular function in rats following long term renal transplantation . Urol Res . 2000;28:97–103
  19. Theocharis SE , Margeli AP , Klijanienko JT , et al.   Metallothionein expression in human neoplasia . Histopathology . 2004;45:103–118
  20. Wang J , Song Y , Elsherif L , et al.   Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation . Circulation . 2006;113:544–554
  21. Cherian MG , Jayasurya A , Bay BH . Metallothioneins in human tumors and potential roles in carcinogenesis . Mutat Res . 2003;533:201–209
  22. Ioachim EE , Kitsiou E , Carassavoglou C , et al.   Immunohistochemical localization of metallothionein in endometrial lesions . J Pathol . 2000;191:269–273
  23. Summer KH , Drasch GA , Heilmaier HE . Metallothionein and cadmium in human kidney cortex: influence of smoking . Hum Toxicol . 1986;5:27–33
  24. Andrews GK . Regulation of metallothionein gene expression . Prog Food Nutr Sci . 1990;14:193–258
  25. Davis SR , Cousins RJ . Metallothionein expression in animals: a physiological perspective on function . J Nut . 2000;130:1085–1088
  26. Milnerowicz H , Chmarek M . Influence of smoking on metallothionein level and other proteins binding essential metals in human milk . Acta Paediatr . 2005;94:402–406
  27. Ronco AM , Arguello G , Suazo M , et al.   Increased levels of metallothionein in placenta of smokers . Toxicology . 2005;208:133–139
  28. Sorkun HC , Bir F , Akbulut M , et al.   The effects of air pollution and smoking on placental cadmium, zinc concentration and metallothionein expression . Toxicology . 2007;238:15–22

PII: S0929-6646(09)60373-9

doi:10.1016/S0929-6646(09)60373-9

Journal of the Formosan Medical Association
Volume 108, Issue 7 , Pages 554-559, July 2009

Article Tools